CRYOSTEM and Modul-Bio are presenting a poster at the ISBER 2020 virtual symposium as part of the management of the CRYO-LEA * cohort using the MBioLIMS BioBanking® software.

Launched in 2018, the CRYO-LEA cohort allows the valuation of epidemiological and clinical data from LEA (one of the 2 most important prospective cohorts in the world focused on childhood leukemia) within a new collection of biological resources constituted and managed by the CRYOSTEM;

The objective of the CRYO‐LEA cohort is to predict the occurrence of late side effects (cardiac, metabolic, tumor, etc.) in patients treated for leukemia with chemotherapy and / or bone marrow transplant during childhood;

The CRYO-LEA cohort is one of 8 medico-scientific projects registered in the international research, training and innovation program of the HTC Project endowment fund dedicated to the complications of bone marrow transplantation.

Link on the CRYO-LEA poster

Learn more about the ISBER 2020 Virtual Symposium program